Assessment of Cancer Care Costs in Disease-Specific Cancer Care Pathways
| Autor: | William Balzi, Davide Gallegati, Ilaria Massa, Mattia Altini, Laura Solinas, Nicola Gentili, Lauro Bucchi, Fabio Falcini |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Total cost Health Toxicology and Mutagenesis Population lcsh:Medicine Disease healthcare cost Article State Medicine 03 medical and health sciences 0302 clinical medicine administrative data Ambulatory care Neoplasms Health care Ambulatory Care medicine Per capita Humans 030212 general & internal medicine Gastrointestinal cancer education health care economics and organizations education.field_of_study business.industry lcsh:R Public Health Environmental and Occupational Health Cancer Health Care Costs medicine.disease Hospitalization Italy cancer care cost 030220 oncology & carcinogenesis Emergency medicine Health Expenditures business care pathway |
| Zdroj: | International Journal of Environmental Research and Public Health International Journal of Environmental Research and Public Health, Vol 17, Iss 4765, p 4765 (2020) Volume 17 Issue 13 |
| ISSN: | 1660-4601 |
| DOI: | 10.3390/ijerph17134765 |
| Popis: | In view of an efficient use of the Italian National Health Service-funded healthcare resources, a novel data-processing strategy combining information from multiple sources was developed in a regional cancer network of northern Italy. The goal was to calculate the annual overall cost of care pathways of six disease groups in 10,486 patients. The evaluation was conceived as a population-based cost description from the perspective of the Italian National Health Service. Costs occurred during a defined time period for a cross-section of patients at varying stages of their disease were measured. The total cancer care cost was &euro 81,170,121 (11.1% of total local health expenditure), with a cost per patient of &euro 7741.17 and a cost per capita of &euro 204.62. Surgical, inpatient and day-hospital medical admissions, radiotherapy, drugs, outpatient care, emergency admissions, and home and hospice care accounted for 21.2%, 24.1%, 6.2%, 28.2%, 14.0%, 0.9%, and 5.4% of the total cost, respectively. The highest cost items included drugs (cost per capita, &euro 22.95 11.2% of total cost) and medical admissions (&euro 14.51 7.1%) for blood cancer, and surgical (&euro 14.56 7.1%) and medical admissions (&euro 13.60 6.6%) for gastrointestinal cancer. The information extracted allows multidisciplinary cancer care teams to be more aware of the costs of their clinical decisions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|